CTRI/2019/03/018247
Not yet recruiting
Phase 4
Evaluation of the efficacy of sticky bone and concentrated growth factor (CGF) membrane along with a coronally advanced flap (CAF) as compared to coronally advanced flap alone in the treatment of Millers class I and class II gingival recession defects. - SBCGF
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Terna Dental College
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1 Patients with Millers class I and/or
- •class II recession defects.
- •2 Patients between the age group of 18 â?? 60 yrs.
- •3 Patients maintaining good oral hygiene.
- •4 Systemically healthy patients.
- •5 Patients who give informed consent to participate in the study.
- •6 Patients who do not consume tobacco in any form.
Exclusion Criteria
- •1 Pregnant and lactating females.
- •2 Patients who have undergone any periodontal surgical therapy in the last 6 months in the same site.
- •3 Patients taking anticoagulants and anti\-platelet drugs
- •4 Patients with allergies to materials used in treatment process
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Comparison of sticky bone with xenograft for bone regeneration in periodontal defect-A Randomised controlled clinical & radiographic studyCTRI/2020/03/023751ISHANTA BORA
Not yet recruiting
Phase 2
Platelet Rich Fibrin is Compared with Sticky Bone in the evaluation of Post Operative Healing Following Surgical Extraction of Third Molar-A Randomized Control Trail.Health Condition 1: K011- Impacted teethCTRI/2024/07/069712Sharanya Jillapally
Recruiting
Phase 1
Ridge augmentation done for bone defects using a combination of platelet concentrate and graft material.CTRI/2020/06/025567Jane BelindaT
Not yet recruiting
Not Applicable
Effect of sticky bone with and without decoration in periodontal intrabony defectsCTRI/2023/01/049209Tripti Mohan
Completed
Not Applicable
A clinical study to evaluate the efficacy of bone-modyfying agent for the patients of prostate cancer.JPRN-UMIN000015126Department of Urology, Keio University School of Medicine